MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Depression"

  • 2022 International Congress

    Depression and progression of motor symptoms in early stage of Parkinson’s disease

    YS. Hwang, SJ. Chung (Seoul, Republic of Korea)

    Objective: To investigate the association of depression with the progression of motor symptoms in patients with early-stage PD. Background: Depression is a major nonmotor symptom…
  • 2022 International Congress

    Parkinson’s Disease and Psychosocial Impact: Anxiety, Depression and Positive Symptoms

    O. Kaczmarek, S. Baek, A. Sethi, A. Stolarczyk, B. Bumstead, B. Anand, M. Buhse, M. Zarif, M. Gudesblatt (Patchogue, USA)

    Objective: Explore the relationship between patient self-reported assessment of positive symptoms, depression, and anxiety in PwPD. Background: Parkinson’s disease (PD) is a complex neurodegenerative disorder…
  • 2022 International Congress

    Childhood Trauma and Parkinson’s Disease: Associations of Adverse Childhood Experiences, Disease Severity and Quality of Life

    I. Subramanian, B. Mcdaniels, J. Farahnik, L. Mischley (Los Angeles, USA)

    Objective: Objective: The goal of this study was to survey individuals with PD to evaluate whether intensity of childhood trauma is associated with individual symptoms,…
  • 2022 International Congress

    Chronotype and Cognition in Veterans with Parkinson’s Disease

    A. Sarwar (Houston, USA)

    Objective: To determine if chronotype impacts the expression of dementia and/or depression in Veterans with Parkinson's disease (PD). Background: Chronotype reflects the periodicity of biological…
  • 2022 International Congress

    A Randomized, Wait-List Controlled Trial of the Feasibility and Efficacy of Small Group Online-based Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease

    N. Nishikawa, T. Hatano, C. Uchida, Y. Ouji, N. Miyamoto, G. Oyama, N. Hattori (Tokyo, Japan)

    Objective: To investigate the feasibility and efficacy of online-based Cognitive Behavioral Therapy (CBT) for anxiety in Parkinson's disease (PD). Background: Anxiety symptoms in Parkinson's disease…
  • 2022 International Congress

    Sigma Absolute Spectral Power is Associated with Depression in Parkinson’s Disease

    A. Memon, C. Catiul, Z. Irwin, J. Pilkington, A. Joop, R. Memon, K. Wood, G. Cutter, S. Miocinovic, A. Amara (Birmingham, USA)

    Objective: This cross-sectional study investigated the relationship between depression and sigma absolute spectral power (9-15 Hz) in the frequency range of sleep spindles during non-rapid…
  • 2022 International Congress

    Screening and Treatment of Depression in Parkinson’s Disease within Movement Disorders Centers: A Quality Improvement Initiative

    Z. Meyer, C. Marras, A. Naito, N. Dahodwala, A. Ramirez-Zamora, M. Rose Rafferty, M. Neault, J. Beck, R. Deleon, T. Davis, S. Mantri, K. Mills, J. Miyasaki, E. Nelson, A. Brown, D. Weintraub, A. Allen (Miami, USA)

    Objective: Assess the feasibility of systematic depression screening of people with Parkinson’s (PWP) and determine barriers in the specialist movement disorders setting. Background: While depression…
  • 2022 International Congress

    Longitudinal study of clinical symptoms associated with psychosis in Parkinson’s disease without dementia

    J. Flanigan, M. Harrison, B. Shah, J. Patrie, K. Wyman-Chick, W. Dalrymple, S. Sperling, M. Barrett (Charlottesville, USA)

    Objective: Examine clinical features associated with psychosis among Parkinson’s disease (PD) patients without dementia. Background: Previously identified risk factors for PD psychosis include duration and…
  • 2022 International Congress

    Epidemiologic And Clinical Features Of Psychiatric Disorders In Patients With Parkinson’s Disease – A Retrospective Cohort Study

    O. Koniashvili, G. Khachiashvili, L. Gabunia (Tbilisi, Georgia)

    Objective: We aimed to assess the average duration of Parkinson's disease at the time patient was diagnosed with specific neuropsychiatric disturbance, to study their prevalence…
  • 2022 International Congress

    Correlation between cognitive impairment and neuropsychiatric symptoms in Mexican persons living with Parkinson’s disease.

    GI. Cerda-Hernández, AJ. Hernández-Medrano, P. Bazán-Rodríguez, E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, MA. Ruiz-Mafud, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante, R. Solís-Vivanco (Mexico City, Mexico)

    Objective: To describe the association amongst depression, anxiety, psychosis with cognitive impairment in Mexican people living with Parkinson’s disease (PwP). Background: Cognitive impairment and neuropsychiatric…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 36
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley